resources

Beryl Drugs Ltd.

BSE: 524606

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

24.89-0.1 (-0.44%)

22 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Beryl Drugs Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Beryl Drugs Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS, 2018 FOR THE QUARTER ENDED 30.09.2026
57 (5) : intimation after the end of quarter7 Oct 2026
Compliance-57 (5) : intimation after the end of quarter
NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026
Closure of Trading Window30 Sept 2026
Closure of Trading Window
CLOSURE OF TRADING WINDOW
AGM30 Sept 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026
AGM29 Sept 2026
PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026
PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING
General29 Sept 2026
Approval For Increase In The Limit Of Material Related Party Transactions With M/S. Aminova Infusions Pvt. Ltd.
considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD.
AGM29 Sept 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
OUTCOME OF 33RD ANNUAL GENERAL MEETING
Newspaper Publication6 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
NEWSPAPER PUBLICATION OF 33RD ANNUAL GENERAL MEETING NOTICE
Reg. 34 (1) Annual Report3 Sept 2026
Reg. 34 (1) Annual Report.
ANNUAL REPORT 2025-2026
AGM3 Sept 2026
33RD ANNUAL GENERAL MEETING NOTICE TO BE HELD ON 29TH SEPTEMBER, 2026 AT 11 A.M. AT KANCHAN PALACE COMMUNITY HAII, NIPANIA RING ROAD, INDORE
33RD ANNUAL GENERAL MEETING NOTICE
General3 Sept 2026
EVOTING DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING
EVOTING DATES FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING
Record Date3 Sept 2026
RECORD DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING
RECORD DATE
Outcome of Board Meeting2 Sept 2026
Board Meeting Outcome for OUTCOME OF BOARD MEETING
OUTCOME OF BOARD MEETING
Board Meeting27 Aug 2026
Board Meeting Intimation for Approve Board Report And Other Matters Related To 33Rd Annual General Meeting Of The Company
Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve approve board report and other ....
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201120 Aug 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Aug 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
Newspaper Publication13 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
NEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026
Outcome of Board Meeting11 Aug 2026
Board Meeting Outcome for OUTCOME OF BOARD MEETING
OUTCOME OF BOARD MEETING
Board Meeting5 Aug 2026
Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June, 2026
Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the unaudited financial results ....
General21 Jul 2026
Intimation Regarding Temporary Unavailability Of The Company''s Website Due To An Unexpected Technical Issue
TEMPORARY UNAVAILABILITY OF THE COMPANY''S WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.

Frequently Asked Questions

Where can I download the annual report of Beryl Drugs Ltd.?

Annual reports of Beryl Drugs Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Beryl Drugs Ltd.?

Quarterly earnings results and presentations of Beryl Drugs Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Beryl Drugs Ltd. publish earnings call transcripts?

Earnings call transcripts of Beryl Drugs Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Beryl Drugs Ltd.?

Investor presentations and annual day presentations of Beryl Drugs Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Beryl Drugs Ltd.?

Corporate announcements and regulatory filings of Beryl Drugs Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Beryl Drugs Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Beryl Drugs Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Beryl Drugs Ltd.?

The ISIN (International Securities Identification Number) of Beryl Drugs Ltd. is INE415H01017. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Beryl Drugs Ltd. listed?

Beryl Drugs Ltd. is listed on NSE and BSE. The NSE symbol is BERLDRG and the BSE code is -.

Where can I find the shareholding pattern of Beryl Drugs Ltd.?

The quarterly shareholding pattern of Beryl Drugs Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Beryl Drugs Ltd. on Sharpely?

Share price data for Beryl Drugs Ltd. is updated as of 22 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.